2021: Wednesday 8 December Netcare Limited has been approved for a secondary listing on A2X Markets and its shares will be available for trade on A2X from 15 December 2021.
Netcare Limited, which operates the largest private hospital, primary healthcare, emergency medical services, mental health and renal care networks in South Africa will retain its primary listing on the Johannesburg Stock Exchange (JSE) and its issued share capital will be unaffected by its secondary listing on A2X.
Netcare CEO, Dr Richard Friedland said, “This month we celebrate 25 years since the group first listed on the JSE. In 1996 we owned just four hospitals compared to the current 51. A quarter of a decade and considerable growth later, we are pleased to be complementing our primary listing with a secondary listing on A2X. Continuous innovation is a core part of Netcare’s approach to better healthcare and being able to offer our investors a parallel cost effective benefit by listing on A2X, supports this value.”
Kevin Brady, CEO of A2X Markets said, “A warm welcome to our first healthcare group in the hospital sector to list on A2X. This listing will provide investors with the opportunity to capture the benefits made available by using the latest exchange technology. These include added liquidity, narrower spreads and reduced exchange fees.”
Brady added, “The medical community has been at the front-line of the covid pandemic and we at A2X would like to express our huge gratitude to all healthcare workers and professionals. We are particularly proud to be welcoming Netcare to our market at this time”.
The listing on 15 December will bring the number of instruments available for trade on A2X to 59 with a combined market capitalisation of over R5 trillion. Netcare joins other well-known companies including Aspen, Exxaro, Growthpoint, Investec, Mr Price, Naspers, Prosus, Standard Bank, Sanlam and Sasol.
A2X is a licensed stock exchange that provides a secondary listing venue for companies. It is regulated by the Financial Sector Conduct Authority and the Prudential Authority (SARB) in terms of the Financial Markets Act. A2X began trading in October 2017.
The Netcare Group (JSE: NTC) offers a unique, comprehensive range of medical services across the healthcare spectrum, enabling us to serve the health and care needs of each individual who entrust their care to us. Our focus on implementing sophisticated digital systems will enable us to provide care that is fully integrated and an enhanced experience across our Group’s operations. At Netcare, we are striving to change healthcare for the better. In addition to our world-class acute private hospital services, Netcare provides:
- radiosurgery, radiotherapy, chemotherapy, bone marrow transplant and robotic-assisted surgery through Netcare Cancer Care;
- primary healthcare services through Medicross;
- emergency medical services through Netcare 911;
- occupational health and employee wellness services through Netcare Occupational Health;
- mental health and psychiatric services through Akeso;
- innovative solutions to increase access to quality and affordable private healthcare through NetcarePlus; and
- renal dialysis services through National Renal Care (NRC).
Netcare is also a leading private trainer of emergency medical and nursing personnel in the country.
For more information visit www.netcare.co.za.
A2X Markets (A2X) is a South African stock exchange that plays an integral part in the progression of the South African marketplace. An experienced team, advanced technology and an agile environment enable A2X to provide an efficient and cost-effective trading venue to secondary list and trade shares, exchange traded funds (ETFs) and exchange traded notes (ETNs).
A2X appointed Strate as its central securities depository and operates within the proven and reliable South African settlement structure, using technology developed by the UK’s Aquis Technologies, which includes proven exchange matching and surveillance systems and a clearing platform custom-built for A2X. The end-to-end costs of transacting on A2X are about 50% lower than at the other South African trading venue where the same shares can be traded.
Netcare CEO, Richard Friedland
A2X CEO Kevin Brady:
For further information, photographs or interviews for A2X, please contact Diane Bomberg, C 082 641 9244 email@example.com